Biblio
“Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial.”, J Alzheimers Dis, vol. 61, no. 1, pp. 435-457, 2018.
, “Histopathology and Florbetaben PET in Patients Incorrectly Diagnosed with Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 2, pp. 441-446, 2017.
,